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Baseline characteristics
Patient n¼21
Age(years) 44.866.48
Female/male 20/1
NYHA 2.714.63
MVA(cm2) 1.200.25
Mean transmitral gradient(mmHg) 12.15.54
Left atrium(cm) 4.790.6
Ejection Fraction(%) 54.812.1
NYHA:New York Heart Association MVA:Mitral valve area
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Relationship between Aortic Stenosis and Fragmented QRS
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Nuri Bülent Boyacı1
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Introductıon: Fragmented QRS (fQRS) is accepted as a marker of myocardial scar
caused by depolarisation defect. In recent studies, it was showed that fQRS is an
indicator of ischemia and infarct. In ischemic cardiomyopathy, Brugada syndrome and
arrhythmogenic right ventricular dysplasia, fQRS is predictor of arrhythmia attacks
and mortality. In mitral stenosis fQRS is seen more frequent than healthy people and it
is predictive of severe mitral stenosis, myocardial dysfunction and inreased pulmonary
arterial pressure. The aim of our study is to assess the relationship between fQRS and
severity of valve stenosis, left ventricular hypertrophy, decompanse diastolic heart
failure and atrial ﬁbrillation in aortic stenosis patients.
Meterial and Method: We evaluated aortic stenosis patients with the mean gradient
over 20 mmHg in aortic valve. Patients with mitral stenosis, tricuspit stenosis, history
of myocardial infarction, documented severe coronary arterial disease, nonischemic
dilate cardiomyopathy, pacemaker ritm, electrolit disturbances and right or left bundle
branch block were excluded. The study included 59 patients. For all patients12 leads
ECG was recorded. Complete echocardiography performed, peak and mean trans-
aortic systolic gradients, aortic jet velocity, septum and posterior wall thicknesses,
diameter of ascendan aorta, left atrial size, ejection fraction and maksimum systolic
pulmonary arterial pressure of patients were recorded. Electrocardiographies are
assessed by two cardiologists unaware of the echocardiography results. Finally,
patients divided into two groups as fQRS established group and others. Echocardio-
graphic and clinical ﬁndings of the groups were compared.
Results: The study included 59 patients. Mean age of the patients was 6914,8 years.
27 subjects (45%) were men, 32 (55%) were women. fQRS was found in 44 (74%)
subjects’ ECG. Age, gender, ejection fraction, septum and posterior wall thicknesses,
left atrial size, aortic dimension, atrial ﬁbrillation ratio and peak systolic transaortic
gradients were similar in two groups. In fQRS group, median systolic transaortic
gradient was signiﬁcantly higher (median 35, interquartile range 20 vs. median 25,
interquartile range 21, p¼0.042). Decompansated diastolic heart failure ratio was
36.3% in fQRS group but only %6.6 in non-fQRS group (p¼ 0.025). Mean maximum
systolic pulmonary arterial pressure was 43 mm Hg in fQRS group and 32 mm Hg in
non-fQRS group (p¼0.035).
Conclusıon: In our study, 74% of aortic stenosis patients had fQRS in their ECGs.
Aortic stenosis patients with fQRS had higher mean systolic transaortic gradients,
higher ratio of decompansated heart failure and maximum systolic pulmonary arterial
pressures than non- fQRS aortic stenosis patients.
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Aım:Mitral stenosis has profound effects on circulation and hemodynamics. However
data about the impact of mitral stenosis on aortic elastic properties are lacking. We
sought to determine the association between mitral stenosis and aortic elastic prop-
erties by using strain and distensibility as a surrogate.
Methods: Sixty six patients with echocardiographic documentation of rheumatic
mitral stenosis and, age and sex matched 25 healthy subjects were enrolled to the
study. Aortic elasticity parameters including strain and distensibility was measured by
means of echocardiography.
Results: The mean age of the patient and control groups were 41.812 and 38.95
years respectively (p¼0.12). There was a signiﬁcant impairment in distensibilty and
strain in the patient group compared to control group (0.2760.167 ve 0.4910.260,
p¼0.001; 6.543.18 ve 9.194.78,p¼0.015). There was a strong correlation between
distensibility and left atrium diameter (p<0.001; R¼ -0.39), left atrial volume index
(p<0.001; R¼ -0.56), mitral valve area (p<0.001; R¼0.40) mean transmitral gradient
(p¼0.022; R¼ -0.18). Strain was also associated with left atrium diameter (p¼0.002;
R¼ -0.32), left atrial volume index (p<0.001; R¼ -0.41), mitral valve area (p¼0.002;
R¼0.31) and mean transmitral gradient (p¼0.035; R¼ -0.18)
Conclusıon: Mitral stenosis is associated with impaired aortic elasticity. Further
studies are need to be disclose the clinical signiﬁcance of this ﬁnding.
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Early Outcome of Mitral Valve Repair for Mitral Regurgitation
Selim _Isbir1, Koray Ak1, Halil Ünal2, Murat Sünbül2, Emre Elçi1, Kürs¸at Tigen2,
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Istanbul, 2Marmara University Medical School, Department of Cardiology, IstanbulJACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTMitral valve repair is considered to be the ideal treatment for both ischemic and
degenerative diseases.
All 58 patients who had mitral valve repair for mitral regurgitation from 2010 to
2012 were prospectively followed for up to 24 months (mean 16.36.4, range 6-24).
Mean age was 62.4611.07 (33-82). Clinical, hemodynamic and operative variables
were evaluated for their association with operative and follow up mortality and
morbidity. There were 30 ischemic and 26 degenerative mitral disease. Two patients
were operated for IHSS. Six patients (23%) had isolated anterior mitral leaﬂet
prolapse, eight patients had (30%) had isolated posterior leaﬂet prolapse and 12
patients (46%) had bileaﬂet mitral leaﬂet prolapse. Mean Euroscore was 9.413.3 and
logistic Euroscore was 2016.3.Operative mortality for ischemic mitral disease was
13.4% (4/30) and 4% (1/26) for degenerative mitral valve disease. Pulmonary
hypertension, high regurgitant volume and ERO were predictors for operative
mortality. Follow up was complete in 44% of patients. Among them 11 patients had
control echocardiography. During the follow up none of the patienst had severe
reccurrent MR. Moderate MR was found in one patient with ischemic MR. Six
patients had trivial MR.
In conclusion, mitral valve repair for ischemic mitral disease in high risk patients is
durable and can be performed with acceptable mortality. Mortality is much lower in
degenerative mitral disasea and repair is also durable in those patients.
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Background: Percutaneous balloon mitral valvuloplasty (PBMV) should be consid-
ered as the ﬁrst-line therapy in most patients with mitral valve stenosis.
Purpose: To evaluate acute clinical, hemodynamic, echocardiographic, and long-term
outcomes of PBMV in patients with a previous closed mitral commissurotomy
(CMC).
Method: Twenty-one rheumatic mitral stenosis patients with histories of CMC were
studied between 1994 and 2010. The PBMV was performed with an Inoue balloon,
and the ideal balloon size was measured according to the patient's height. All patients
underwent standard transesophageal (TEE) and transthoracic (TTE) echocardiographic
examinations before and after the PBMV. Follow-up was scheduled every 6 months
during the ﬁrst year, and yearly thereafter.
Results: The PBMV was successful in all of the patients (mean age 44.866.48
years). The Wilkins score was 8.951.687, and the procedure time was 30.2110.23
minutes, with a mean of 2.451.14 for the balloon inﬂation. The baseline charac-
teristics are shown in Table 1. After the procedure, the post-PBMV mitral valve area
(MVA) was signiﬁcantly larger, with a low mean transmitral gradient (MVA
1.200.25 vs. 1.820.33 p<0.01, mean transmitral gradient 12.105.54 vs.
5.812.31 p<0.01). The pulmonary capillary wedge pressure (PCWP) signiﬁcantly
decreased after PBMV (25.628.6 vs. 13.956.87, p<0.01). The duration of follow-
up was 83.439.5 months, and there were no mortalities. Five patients of 21
underwent mitral valve replacement (MVR), and one had a second PBMV due to
restenosis. At the ﬁnal follow-up appointment, the resting MVA was 1.570.47 cm2,
and the mean transmitral gradient was 8.334.45 mmHg.
Conclusıon: PBMV is an effective therapy, with excellent immediate results in
patients with previous CMCs; however, long-term results revealed more restenosis
than expected. Additionally, the need for MVR was high.PP-402
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Purpose: The predisposition to atrial ﬁbrillation (AF) in aortic stenosis (AS) has been
demonstrated in several studies. P wave dispersion has been performed in the
assessment of the risk for atrial ﬁbrillation. This study aimed to determine the acuteERS C241
Clinical and laboratory characteristics of patients and control subjects.
Variables AS (-) n¼83 AS (+) n¼87 P
Age, years 75  9 76  7 NS
Male gender, n (%) 36 (43) 30 (35) NS
Hypertension, n (%) 33 (40) 51 (59) 0.02
Diabetes, n (%) 5 (6) 12 (14) NS
Smoking, n (%) 17 (20) 11 (13) NS
Hypercholesterolemia,
n (%)
9 (11) 13 (15) NS
fQRS, n (%) 15 (18) 40 (46) <0.001
Cardiovascular
medications
ASA, n (%) 3 (4) 6 (7) NS
b-blocker, n (%) 10 (12) 13 (15) NS
Cholesterol lowering
drugs, n (%)
7 (8) 8 (9) NS
ACEI or ARB, n (%) 14 (17) 29 (33) 0.01
ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; ASA, ace-
tylsalicylic acid; fQRS, fragmented QRS; NS, non-signiﬁcant.
Clinical and laboratory characteristics of subjects with or without fQRS.
Variables fQRS (-) n¼115 fQRS (+) n¼55 P
Age, years 75  8 76  7 NS
Male gender, n (%) 48 (42) 18 (33) NS
Hypertension, n (%) 52 (45) 32 (58) NS
Diabetes, n (%) 9 (8) 8 (15) NS
Smoking, n (%) 22 (19) 6 (11) NS
Hypercholesterolemia,
n (%)
15 (13) 7 (13) NS
Aortic stenosis, n (%) 47 (41) 40 (73) <0.001
Cardiovascular
medications
ASA, n (%) 7 (6) 2 (4) NS
b-blocker, n (%) 16 (14) 7 (13) NS
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immediately after aortic valvuloplasty and prosthesis deployment.
Methods -Results: This single-center study consisted of 32 patients with severe AS
(23 females and 9 males, aged 76.46.9 years, with a mean aortic gradient of
51.98.9 mmHg) who underwent successful TAVI without complication. A
comprehensive electrocardiographic study was performed before and 24 hours after
TAVI. Electrocardiographic and echocardiographic parameters after TAVI were
compared with previous values. PWD values before the procedure were correlated
with the mean aortic valve gradient (r:0.396, p:0.025). After the procedure, the PWD
values were signiﬁcantly smaller than before operation (59,514,1 vs 51,912,
p:0,005).
Conclusıons: This is the ﬁrst study describing improvement of PWD after TAVI. Our
results show TAVI provides reduction in the risk of AF, as well as the hemodynamic
beneﬁts
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Background: Several studies indicate that the quantitative assessment of myocardial
ﬁbrosis has the potential to provide additional prognostic information in the evaluation
of patients with severe aortic valve stenosis. Recently, fragmented QRS is considered
to reﬂect myocardial ﬁbrosis.
Aım: In present study, we aimed to investigate the presence and frequency of
myocardial ﬁbrosis determined by fragmented QRS in patients with severe aortic
valve stenosis.
Methods: Consecutive 87 patients with severe aortic valve stenosis and age- gender
matched 83 control subjects were enrolled. Patients with signiﬁcant concomitant
valvular disease, established coronary artery disease by history or angiography at
index hospitalization, wall motion abnormalities and severe pulmonary disease were
excluded. Severe aortic valve stenosis was deﬁned as aortic valve area <1 cm2 or
Vmax >4 m/second or mean gradient 40 mmHg. The fQRS was deﬁned as the
presence of various RSR' patterns (QRS duration <120 ms) with which included an
additional R wave (R'), notching of the R wave or S wave, or the presence of more
than one R' (fragmentation) without a typical bundle branch block in two contiguous
leads corresponding to a major lead set for major coronary artery territory (Fig. 1).
Results: Fragmented QRS was detected in 40 (46%) patients in aortic valve stenosis
group and in 15 (18%) control subjects (p<0.001) (Table 1). Study population was
divided into two groups according to the having fQRS or not in order to identify
independent determinants of fQRS (Table 2). Factors presented in Table 2 were
entered in multivariate binary logistic regression analysis. In multivariate binary
logistic regression analysis, presence of aortic valve stenosis was the only independent
factor associated with the fragmented QRS (OR, 3.69; 95% CI, 1.81-7.55, p < 0.001).
Conclusıon: We have detected ﬁrst time increased frequency of fragmented QRS in
patients with severe aortic valve stenosis.Cholesterol lowering
drugs, n (%)
10 (9) 5 (9) NS
ACEI or ARB, n (%) 26 (23) 17 (31) NS
ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; ASA, ace-
tylsalicylic acid; fQRS, fragmented QRS, NS, non-signiﬁcant.
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Introductıon: Aortic valve surgery is the standart therapy of symptomatic severe
aortic stenosis (AS). But Transcatheter Aortic Valve Implantation (TAVI) has been
a recently established treatment for the patients inoperable or high risk for valve
surgery. In Europe and in our clinic two of the devices mostly used for TAVI are
Edwards SAPIEN (Edwards Lifesciences, Irvine, CA) and CoreValve System
(Medtronic Inc., Minneapolis, MN). The aim of this study is presenting the short term
effects of TAVI on echocardiographic outcomes.
Methods: The short term postprocedural echocardiographic parameters of 36 patients
who underwent TAVI in our clinic between 01 June 2012 and 31 May 2013 were
studied. Edwards Sapien or CoreValve bioprotesis valves implanted to all of the
patients by transfemoral approach (by surgical cut down or percutaneously). Echo-
cardiographic parameters of the baseline and 1 month after the procedure were
compared.
Results: Procedural succes rate was %100 (36/36). The mean age of the patients was
78.57.6. Twenty (55,6%) of the patients were female. The Logistic EuroScore was
36.414.3 (Table 1). Twenty six (72%) of the patients had been implanted withl 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
